One-fourth of transvenous implantable cardioverter defibrillator (ICD) leads has a mechanical complication within 10 years, according to an insurance database analysis published May 10 in the Journal of the American Heart Association.
Wearable sensors and artificial intelligence (AI) could help predict the onset of cardiovascular disease by assessing an individual's changes in aerobic responses, according to new research published on Feb. 23 in the Journal of Applied Physiology.
Even for patients with intermittent atrial fibrillation (AFib), the amount of time spent in an arrhythmic state is strongly associated with an increased risk of stroke, researchers reported in JAMA Cardiology.
A His bundle pacing (HBP) strategy was associated with a significant reduction in hospitalizations for heart failure when compared to pacemaker implantation via the right ventricle, according to a study published online May 14 in the Journal of the American College of Cardiology.
Women who received catheter ablation in the FIRE AND ICE trial were 37 percent more likely than men to have a recurrence of atrial arrhythmia and 36 percent more likely to be rehospitalized for cardiovascular causes, according to an analysis published April 26 in Circulation: Arrhythmia and Electrophysiology.
Watchman-related thrombi developed in 3.7 percent of patients who were implanted with the device, resulting in a threefold risk of stroke or systemic embolism, according to a meta-analysis of clinical trials and registries published online May 11 in Circulation.
A novel device placed under the sternum outside of the heart and veins has the potential to deliver pacing and defibrillation therapy, according to a feasibility study presented at the Heart Rhythm Society’s annual scientific sessions.
A sensing filter added to Boston Scientific’s Emblem subcutaneous implantable cardioverter defibrillators (S-ICDs) more than halved the number of inappropriate shocks given to patients over a one-year period, according to a real-world European study presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.
Atrial fibrillation (AFib) should never be considered fully cured, according to a recent study in The BMJ, because patients with this designation carry higher risks of stroke and death compared to people who have never had the arrhythmia.
Catheter ablation was found to be superior to optimal drug therapy for the primary treatment of atrial fibrillation (AFib) in the randomized CABANA trial presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston. However, there was a caveat.
Administering antibiotics incrementally in the perioperative stage has the potential to modestly reduce infections related to cardiac implantable electronic devices (CIEDs), according to a study presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.
An analysis of more than one million post-9/11 veterans suggests a new diagnosis of post-traumatic stress disorder (PTSD) is associated with a greater likelihood of developing atrial fibrillation (AF). The study is scheduled to be presented May 11 at the Heart Rhythm Society’s annual scientific sessions in Boston.
Occluding the left atrial appendage with the Watchman device proved to be a cost-effective strategy for the secondary prevention of stroke among patients with atrial fibrillation (AFib), according to an analysis published in Stroke.
Medtronic’s Micra Transcatheter Pacing System (TPS) demonstrated a major complication rate of 2.7 percent through one year, according to data from a post-approval registry that will be presented May 10 at the Heart Rhythm Society’s annual scientific sessions in Boston.
An intraoperative imaging and mapping system designed to aid in the ablation of complex cardiac arrhythmias was successfully used for the first time in the United States, according to an article distributed by Penn Medicine.
A new nationwide study from Japan highlighted the importance of timely ambulance arrival, showing that bystander defibrillation and cardiopulmonary resuscitation (CPR) for out-of-hospital cardiac arrest are essentially worthless if EMS response times are slower than 13 minutes and 11 minutes, respectively.
A new meta-analysis found double antithrombotic therapy following PCI for patients with atrial fibrillation (AFib) was associated with 47 percent fewer bleeding events than triple therapy and similar rates of major adverse cardiac events.
Physician-manned ambulances could improve the quality of advanced life support given to people who experience traumatic out-of-hospital cardiac arrest (OHCA), suggests a study published April 25 in JAMA Surgery.